Risk factors for lower bone mineral density in older adults with type 1 diabetes: a cross-sectional study.

[1]  T. Songer,et al.  Predictors of Change in Skin Intrinsic Fluorescence in Type 1 Diabetes: The Epidemiology of Diabetes Complications Study , 2021, Journal of diabetes science and technology.

[2]  R. Eastell,et al.  The Effects of Type 1 Diabetes and Diabetic Peripheral Neuropathy on the Musculoskeletal System: A Case–Control Study , 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  A. Paterson,et al.  Residual β cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia. , 2021, The Journal of clinical investigation.

[4]  V. Denaro,et al.  Sclerostin Regulation, Microarchitecture, and Advanced Glycation End‐Products in the Bone of Elderly Women With Type 2 Diabetes , 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  S. Cummings,et al.  The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: A systematic review and meta-analysis update. , 2020, Bone.

[6]  A. Uitterlinden,et al.  Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End‐Products, Is Associated With Prevalent Vertebral and Major Osteoporotic Fractures: The Rotterdam Study , 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  J. Albers,et al.  Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study , 2020, Diabetes.

[8]  D. Hans,et al.  Clinical Performance of the Updated Trabecular Bone Score (TBS) Algorithm, Which Accounts for the Soft Tissue Thickness: The OsteoLaus Study , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  L. Plotkin,et al.  Short-term pharmacologic RAGE inhibition differentially affects bone and skeletal muscle in middle-aged mice. , 2019, Bone.

[10]  L. Pyle,et al.  Trabecular bone quality is lower in adults with type 1 diabetes and is negatively associated with insulin resistance , 2018, Osteoporosis International.

[11]  A. Christensson,et al.  Reduced kidney function is associated with BMD, bone loss and markers of mineral homeostasis in older women: a 10-year longitudinal study , 2017, Osteoporosis International.

[12]  J. Snell-Bergeon,et al.  Bone mineral density at femoral neck and lumbar spine in adults with type 1 diabetes: a meta-analysis and review of the literature , 2017, Osteoporosis International.

[13]  D. Vashishth,et al.  A direct role of collagen glycation in bone fracture. , 2015, Journal of the mechanical behavior of biomedical materials.

[14]  P. Miller.  Chronic kidney disease and the skeleton , 2014, Bone Research.

[15]  A. Sämann,et al.  High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control , 2014, Osteoporosis International.

[16]  C. Cowie,et al.  The Association of Skin Intrinsic Fluorescence With Type 1 Diabetes Complications in the DCCT/EDIC Study , 2013, Diabetes Care.

[17]  D. Vashishth,et al.  Differences in non-enzymatic glycation and collagen cross-links between human cortical and cancellous bone , 2013, Osteoporosis International.

[18]  J. Albers,et al.  Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications , 2012, Diabetic medicine : a journal of the British Diabetic Association.

[19]  Enzo Grossi,et al.  Low Bone Mineral Density and Its Predictors in Type 1 Diabetic Patients Evaluated by the Classic Statistics and Artificial Neural Network Analysis , 2011, Diabetes Care.

[20]  D. Vashishth,et al.  The relative contributions of non-enzymatic glycation and cortical porosity on the fracture toughness of aging bone. , 2011, Journal of biomechanics.

[21]  I. D. de Boer,et al.  Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[22]  S. Cummings,et al.  Pentosidine and increased fracture risk in older adults with type 2 diabetes. , 2009, The Journal of clinical endocrinology and metabolism.

[23]  P. Odetti,et al.  Advanced Glycation End Products and Bone Loss during Aging , 2005, Annals of the New York Academy of Sciences.

[24]  D. Barrio,et al.  Non-enzymatic glycosylation of a type I collagen matrix: effects on osteoblastic development and oxidative stress , 2001, BMC Cell Biology.

[25]  H. K. Genant,et al.  Standardization of Bone Mineral Density at Femoral Neck, Trochanter and Ward’s Triangle , 2001, Osteoporosis International.

[26]  W. Tamborlane,et al.  Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. , 1999, Diabetes care.

[27]  S L Hui,et al.  Universal Standardization of Bone Density Measurements: A Method with Optimal Properties for Calibration Among Several Instruments , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  A. Silman,et al.  The prevalence of vertebral deformity in European men and women: The european vertebral osteoporosis study , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  M. Nevitt,et al.  Vertebral fracture assessment using a semiquantitative technique , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  A. Cerami,et al.  Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. , 1988, The New England journal of medicine.